Deregulation of the phosphatidylinositol 3-kinase pathway has been shown to be an early event in the development of lung cancer [33], and altered signalling via the epidermal growth factor receptor may lead to the development of lung cancer in patients with COPD [34]. The gene discussed is EGFR; the disease is lung cancer.